# PharmaCyte Biotech, Inc.: Form SC 13D, filed May 30, 2024

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: SC 13D
- Filed: 2024-05-30
- Accepted by EDGAR: May 30, 2024, 20:05 ET
- Period: not reported
- Accession: 0001683168-24-003883
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316824003883/pharm_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316824003883/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316824003883/pharm_sc13d.htm

Filed May 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001683168-24-003883. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.